Privo Technologies Inc. is pleased to announce the appointment of Dr. Albert Collinson as an Independent Non-Executive Director to its esteemed Board of Directors
Who to call at Privo Technologies, and when
A new leader at Privo Technologies brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Privo Technologies raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Privo Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Privo Technologies. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Privo Technologies
Location
Peabody, Massachusetts, United States
About
Privo Technologies is a privately funded, Phase III oncology company that spun out of the world-renowned Langer Laboratory at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, USA. Privo is developing a novel, nanotechnology-based drug delivery platform capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa. This approach eliminates needles, avoids stomach acids, can significantly reduce toxic side effects of drugs and allows for higher dosing where the drugs can be most effective – all of which improve patient outcomes and compliance.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Privo Technologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
PeabodyBiotechnologyHealth CareTherapeuticsBiopharma